IPO Boutique

Adamas Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Adamas Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Adamas PharmaceuticalsADMS -
NASDAQ
$16.00-$18.00 $16.00 $16.853 million4/10/2014
Credit Suisse, Piper Jaffray
Co-Manager(s):
William Blair, Needham & Co.
Health Care
Filing(s):

Filed 2014-03-05
Terms Added 2014-03-26



Adamas Pharmaceuticals Quote & Chart - Click for current quote - ADMS

About Adamas Pharmaceuticals (adapted from Adamas Pharmaceuticals prospectus):
They are a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ADMS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved